ChemicalBook
Shanghai Yifei Biotechnology Co. , Ltd. 企業の連絡先情報
名前:
Shanghai Yifei Biotechnology Co. , Ltd.
電話番号:
021-65675885
電子メール:
customer_service@efebio.com
国籍:
China
ウェブサイト:
http://www.efebio.com
商品の合計数:
11973
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
製品カタログ
Brentuximab
2088770-90-3
BI-6901
2040401-92-9
C23H27N5O3S
PDD00031705
2032096-45-8
C20H22N6O3S3
Atorolimumab
202833-08-7
Lenvervimab
2055006-79-4
UNC2025 hydrochloride
2070015-17-5
C28H41ClN6O
PFB-FDGlu
209540-62-5
C39H32F5NO16
Upacicalcet sodium
2052969-18-1
C11H15ClN3NaO6S
S5A1
2055882-51-2
C27H33N3O4.ClH
Pitavastatin D4
2070009-71-9
C??H??D?FNO?
WAY-239196
N-フェニル-N′-フルフリルオキサミド
205749-56-0
C13H12N2O3
EGFR-IN-99
2068806-31-3
C25H22FN7O3
Golexanolone
2089238-18-4
C21H31NO2
Coleneuramide
コレノイラミド
204200-47-5
C39H68N2O8
Ticalopride
202590-69-0
C14H20ClN3O3
Tepoditamab
2044679-53-8
Belantamab
2061894-48-0
Rolinsatamab
2095467-30-2
PF-06843195
2067281-51-8
C20H25F3N8O4
AZ506
2043321-54-4
C33H40N6O
TU-2100
ビス[2-(エトキシカルボニル)フェニル] ノナンジオアート
207972-39-2
C27H32O8
BMS-195270
202822-23-9
C15H9ClF3N3O2
Cetrelimab
2050478-92-5
SM1-71
2088179-99-9
C24H26ClN7O
PF-06445974
2055776-17-3
C20H15FN4O
PU-H71 HCl
2095432-24-7
C18H22ClIN6O2S
Seclidemstat mesylate
2044953-70-8
C21H27ClN4O7S2
Claficapavir
2055732-24-4
C17H12ClNO4S2
BTM-3528
2054998-45-5
C24H19F4N3O2S2
Kras4B G12D-IN-1
2042365-85-3
C16H21ClN2O4S
2,4-D-d3
2,4-ジクロロフェノキシ-3,5,6-D3-酢酸
202480-67-9
C8H3Cl2D3O3
Allopregnanolone-d4
5Α‐プレグナン‐3Α‐オール‐20‐オン‐17,21,21,21‐D4
203805-85-0
C21H30D4O2
XMU-MP-2
2031152-10-8
C32H33F3N8O2
Vopratelimab
2039148-04-2
Ravagalimab
2050816-56-1
CMX-521
2077178-99-3
C13H17N5O5
TV 3279
209394-29-6
C16H20N2O2
TBI-223
2071265-08-0
C17H20FN3O5
Casein Kinase inhibitor A86
2079069-01-3
C18H25FN6
GSK269962A hydrochloride
2095432-71-4
C29H31ClN8O5
beta-Endosulfan-d4
エンドスルファン-II-D4
203716-99-8
C9H2Cl6D4O3S
Tuvatexib
2055404-90-3
C21H23NO3
Tovinontrine
2062661-53-2
C21H26N6O2
Palazestrant
2092925-89-6
C28H36FN3O
XMU-MP-3
2031152-08-4
C27H27F3N8O
ERK-IN-3 benzenesulfonate
2055597-39-0
C28H31ClFN7O5S
F13714 fumarate
208109-39-1
TNF-α-IN-9
2054199-25-4
C17H14O4
HDAC-IN-52
2075787-77-6
C24H20N4O2
D-Ribose 5-phosphate disodium dihydrate
D-リボース 5-リン酸 二ナトリウム塩 二水和物
207671-46-3
C5H9Na2O8P2H2O
VT-1598
(R)-1,1-ジフルオロ-1-[5-[4-(4-シアノベンジルオキシ)フェニルエチニル]-2-ピリジニル]-2-(2,4-ジフルオロフェニル)-3-(1H-テトラゾール-1-イル)-2-プロパノール
2089320-99-8
C31H20F4N6O2
Prolgolimab
2093956-19-3
Quetmolimab
2084037-83-0
Posenacaftor sodium
2095064-06-3
C27H28NNaO5
Tilpisertib
2065153-41-3
C33H33ClN8O
Rolusafine
2089153-78-4
C19H18N2O2
Avexitide acetate
2051593-46-3
C149H234N40O47S.3C2H4O2
Iroxanadine
203805-20-3
C14H20N4O
Epratuzumab
エプラツズマブ
205923-57-5
SR9011 hydrochloride
2070014-94-5
C??H??Cl?N?O?S
OTS193320
2093401-33-1
C28H30ClN5O4
Izencitinib
2051918-33-1
C22H26N8
Morolimumab
202833-07-6
Sutimlimab
スチムリマブ(遺伝子組換え)
2049079-64-1
Lingdolinurad
2088176-96-7
C17H12BrN3O2
Anticancer agent 7
2088956-21-0
C24H19Cl2F3N2O5S
IRAK4-IN-8
2033070-97-0
C23H23F2N7O2S
FD223
2050524-24-6
C17H12ClN5O2S
Nesuparib
2055357-64-5
C23H24N6O
PSB-16133 sodium
9,10-ジヒドロ-9,10-ジオキソ-1-アミノ-4-[4-(3,4-ジメチルフェニルチオ)フェニルアミノ]アントラセン-2-スルホン酸ナトリウム
2089035-40-3
C28H23N2NaO5S2
(R)-Posenacaftor sodium
2095064-09-6
C27H28NNaO5
BAY 1892005
2036352-13-1
C11H8ClFN2OS
(R)-Azasetron besylate
2025360-91-0
C17H20ClN3O3.C6H6O3S
(Rac)-LB-100
2061038-65-9
C13H20N2O4
Eflucimibe
F-12511
202340-45-2
C29H43NO2S
Iscalimab
2031153-61-2
Abrezekimab
2043952-59-4
Murlentamab
2058047-65-5
Levilimab
2035008-70-7
MAX-40279
2070931-57-4
C22H23FN6OS
GSK3494245
2080410-41-7
C21H23FN6O2
EWP 815
20231-01-0
C12H22N4S4
BTX161
2052301-24-1
C15H16N2O3
K67
N,N′-(2-アセトニルナフタレン-1,4-ジイル)ビス(4-エトキシベンゼンスルホンアミド)
2046250-48-8
C29H30N2O7S2
JHU395
2079938-92-2
C22H29N3O7
Mitazalimab
2055640-86-1
Osocimab
2056878-75-0
Cinpanemab
2094516-02-4
Retifanlimab
2079108-44-2
Mal-amido-PEG3-NHS ester
2055353-77-8
C20H27N3O10
BMS-986224
2055200-88-7
C24H23ClN4O6
AM-8123
2049973-02-4
C27H33N7O5S
Tz-Thalidomide
2087490-42-2
C29H29N7O6
Sirpiglenastat
2079939-05-0
C22H27N5O5
Pumafentrine
207993-12-2
C29H39N3O3
Azelaprag
(2S,3R)-N-[4-(2,6-ジメトキシフェニル)-5-(5-メチル-3-ピリジル)-4H-1,2,4-トリアゾール-3-イル]-3-(5-メチルピリミジン-2-イル)ブタン-2-スルホンアミド
2049980-18-7
C25H29N7O4S
USP30 inhibitor 11
2067332-64-1
C17H16N6O2S
Etigilimab
2044984-83-8
Orilanolimab
2066544-85-0
Sintilimab (anti-PD-1)
2072873-06-2
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Copyright 2017 © ChemicalBook. All rights reserved